Christopher Seekamp

Christopher Seekamp has extensive work experience in the pharmaceutical and chemical industry. Christopher is currently working at On Target Laboratories as the Director of Process Development, CMC. Prior to this, they held the position of Director CMC at Sterling Pharma Solutions from August 2020 to May 2022. Before that, they worked at Alcami Corporation, first as the Director CMC from April 2020 to August 2020, and then as the Director Process Research & Development from August 2014 to April 2020. Christopher also served as a Group Leader, Research and Development at Cambridge Major Laboratories from September 2013 to August 2014. Christopher was the Director of Technology at Fontarome Chemical, Inc. from May 2008 to September 2013. Their earlier experience includes working as a Research Fellow I at Neurogen Corporation from September 2004 to May 2008 and as a Research Fellow IV at The Institute for Diabetes Discovery from April 2004 to August 2004.

Christopher Seekamp received their Bachelor of Science degree in Chemistry from Michigan Technological University from 1994 to 1998. Christopher then pursued further education at The Ohio State University from 1998 to 2004 and obtained their Ph.D. in Chemistry.